Growth Hormone · MetabolicTesamorelin
Growth Hormone-Releasing Hormone (GHRH) Analogue
GHRH analogue investigated in metabolic and growth-hormone research.
EU Delivery: 2–4 Business Days
About this peptide
Tesamorelin is a stabilised GHRH analogue that produces powerful, targeted reduction of visceral adipose tissue — the deep abdominal fat most linked to metabolic disease.
Tesamorelin stimulates the pituitary to release growth hormone in a natural, pulsatile pattern, raising IGF-1 and driving preferential lipolysis of visceral fat. No other peptide targets deep abdominal fat with the same precision.
Beyond visceral fat loss, users experience improvements in lipid profile, cognition, sleep quality and neurological function. It is one of the few peptides shown to enhance cognitive performance in older adults.
The result is a flatter waistline, sharper mind and healthier metabolic profile.
Research profile
Selectively strips deep abdominal fat.
Improves memory and executive function in older adults.
Better lipids, triglycerides and insulin response.
Restores physiological pulsatile GH release.
Research areas
- Powerful, targeted visceral fat loss
- Flatter, tighter midsection
- Improved cognition, memory and focus
- Healthier lipid profile and metabolic markers
- Better sleep and daytime energy
- Firmer skin and stronger connective tissue
Specifications
- Class
- GHRH analogue
- Presentation
- 10 mg lyophilised vial
- Analytical
- Batch tested · HPLC verified
- Storage
- 2–8 °C, protect from light
Verified customer reviews
No reviews yet. Reviews come only from customers with a delivered order.
For research use only. Not intended for human or veterinary therapeutic use.
